Test Catalog

Test ID: FUNSF    
Fungitell, CSF

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

The Fungitell Beta-D Glucan assay is indicated for the presumptive diagnosis of invasive fungal disease through detection of elevated levels of (1,3)- Beta-D-glucan in serum. Normal human serum contains low levels of (1,3)- Beta-D glucan, typically 10 to 40 pg/mL, presumably from commensal yeasts present in the alimentary canal and gastrointestinal tract. However, (1,3)- Beta-D-glucan is sloughed from the cell walls during the life cycle of most pathogenic fungi. Thus, monitoring serum for evidence of elevated and rising levels of (1,3)- Beta-D-glucan provides a convenient surrogate marker for invasive fungal disease.


The Fungitell Beta - D Glucan assay detects (1,3) - Beta-D-glucan from the following pathogens: Candida spp., Acremonium, Aspergillus spp., Coccidioides immitis, Fusarium spp., Histoplasma capsulatum, Trichosporon spp., Sporothrix schenckii, Saccharomyces cerevisiae, and Pneumocystis jiroveci. The Fungitell Beta-D Glucan assay does not detect certain fungal species such as the genus Cryptococcus, which produces very low levels of (1,3) - Beta-D-glucan, nor the Zygomycetes, such as Absidia, Mucor, and Rhizopus, which are not known to produce (1,3) - Beta-D-glucan. Studies indicate Blastomyces dermatitidis is usually not detected due to little (1,3) - Beta-D-glucan produced in the yeast phase.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

A reference range for specimens other than serum has not been established.

Interpretation Provides information to assist in interpretation of the test results

The performance characteristics of the Fungitell assay in CSF have been determined by Viracor-IBT Laboratories; there are no established criteria for the interpretation of Fungitell results from CSF fluid. Research studies have evaluated the use of the Fungitell assay in CSF during a fungal meningitis outbreak (J. Clin. Microbiol. 2013, 51(4):1285-1287).